Laboratory-based surveillance of antimicrobial non-susceptibility in Enterobacter species over 12 years at a tertiary-care hospital in Saudi Arabia
PLOS One · 2026
DOI: 10.1371/journal.pone.0358963 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yahya Shabi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia. Hauptthemen laut MEDLINE: Enterobacter, Anti-Bacterial Agents, Enterobacteriaceae Infections. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Research and Graduate Studies, King Khalid University.
Abstract (Originalsprache)
Background
Enterobacter species are increasingly associated with antimicrobial non-susceptibility, but long-term surveillance of temporal trends across antibiotic classes is limited in southern Saudi Arabia.
Methods
We retrospectively studied non-duplicate Enterobacter isolates from adults at a tertiary-care hospital in southern Saudi Arabia (August 2012–August 2024), interpreted by contemporaneous CLSI criteria. Temporal trends were modelled by logistic regression as the annual percent change (APC) in the odds of non-susceptibility, adjusted for care setting, specimen source, age, and sex. Carbapenem-resistant Enterobacterales (CRE) and difficult-to-treat resistance (DTR; Kadri criteria) were analysed over time; sensitivity analyses excluded partial years and used breakpoint-comparable periods.
Results
Of 1,319 Enterobacter isolates, 91.8% belonged to the Enterobacter cloacae complex. Adjusted trends declined for amikacin (APC −6.1%), gentamicin (−9.4%) and cefepime (−9.1%) and rose for carbapenems (+13.1% to +15.8%), levofloxacin (+6.3%) and piperacillin–tazobactam (+7.0%), with ciprofloxacin stable. The levofloxacin and piperacillin–tazobactam increases did not persist in breakpoint-comparable analyses and are not unequivocal biological increases. Inpatient isolates were more non-susceptible than outpatient isolates by approximately 16–39 percentage points (gentamicin 31.7% vs 14.8%; piperacillin–tazobactam 38.7% vs 23.1%; cefotaxime 63.9% vs 41.5%; cefepime 45.7% vs 28.8%; ceftazidime 61.4% vs 35.3%; ceftriaxone 57.4% vs 18.8%; all p ≤ 0.003). CRE rose early and remained common (APC + 22.8%; 28.7% overall), whereas DTR rose later and stayed infrequent (7.5% of eligible isolates; APC + 16.4%; highest annual value 20.2% in 2023); this difference in timing and overall frequency, not the partially sampled year 2024, indicates dissociation between carbapenem non-susceptibility and loss of all first-line agents.
Conclusion
Non-susceptibility among Enterobacter species was heterogeneous and antibiotic-specific. The dissociation between CRE and DTR in timing and overall frequency supports using clinically meaningful phenotypes alongside antibiotic-specific trend analysis for stewardship and reporting; the levofloxacin and piperacillin–tazobactam increases warrant caution, as they did not persist in breakpoint-comparable analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia.
- Khamis Mushait General Hospital, Khamis Mushait, Saudi Arabia.
- Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Consultant Nephrology and Assistant Professor at King Khalid University, Abha, Saudi Arabia.
- Department of Internal Medicine, Aseer Central Hospital, Abha, Saudi Arabia.
- Department of Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.
ORCID-Profile: Yahya Shabi, Khalifa Binkhamis, Safia Abdullah Mohammed, Abdulah J Alqahtani
Förderung
- Deanship of Research and Graduate Studies, King Khalid University
Zitieren
APA
Shabi, Y., Asiri, F. M. A., Binkhamis, K., Somily, A. M., Alshahrani, M. M., Alazraqi, T., Mohammed, S. A., Habbash, S., Al Bshabshe, A., Mohamed, S., Algarni, A., Siddiq, A., Bawazeer, A. O. S., Alqahtani, A. J., & Al-Shahrani, A. A. (2026). Laboratory-based surveillance of antimicrobial non-susceptibility in Enterobacter species over 12 years at a tertiary-care hospital in Saudi Arabia. PLOS One. https://doi.org/10.1371/journal.pone.0358963
Vancouver
Shabi Y, Asiri FMA, Binkhamis K, Somily AM, Alshahrani MM, Alazraqi T, et al. Laboratory-based surveillance of antimicrobial non-susceptibility in Enterobacter species over 12 years at a tertiary-care hospital in Saudi Arabia. PLOS One. 2026. doi:10.1371/journal.pone.0358963
BibTeX
@article{Shabi2026,
author = {Shabi, Yahya and Asiri, Fatimah Mohmmed Ali and Binkhamis, Khalifa and Somily, Ali M and Alshahrani, Mona M and Alazraqi, Tarik and Mohammed, Safia Abdullah and Habbash, Sara and Al Bshabshe, Ali and Mohamed, Soliuman and Algarni, Abdullah and Siddiq, Ahmadiyah and Bawazeer, Abdulah O S and Alqahtani, Abdulah J and Al-Shahrani, Abdullah A},
title = {Laboratory-based surveillance of antimicrobial non-susceptibility in Enterobacter species over 12 years at a tertiary-care hospital in Saudi Arabia},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0358963}
}
EUVIMED